-
The Effect Of Antidiabetic Agent Glibenclamide And Meltformine On Lipids And Glycated Haemoglobin In Type 2 Diabetes Patient Attending Uith Ilorin
REFRENCES -- [Total Page(s) 3]
Page 2 of 3
-
-
-
Isomaa, I., Drai, J., Bannier, E., Riviere, J., Calmard, P. and Garcia, I. (2001). Oxidative stress parameters in type I, type II and insulin-treated type 2 Diabetes mellitus; insulin treatment efficiency. Pg. 89-96.
Jaber, L.A., Nowak, S.N. and Slaughter, R.R. (2002). Insulin-metformin combination therapy in obese patients with type 2 diabetes. Journal of Clinical Pharmacology. Pg. 89-94.
Jarvinen, H. (1995). Role of insülin resistance in the pathogenesis of NIDMM. Diabetologia. 38:1378-88.
Jarvinen, H., Ryysy, L. and Nikkila, K, (1999) Comparison of bedtime insulin regimens in patients with type 2 Diabetes mellitus. A randomized, controlled trial. Annual Internal Medicine. 130:389-96.
Kabadi,M.U. (2003). Efficacy of sulphonylureas with insulin in type 2 Diabetes mellitus. Pg.1572.
Kaku, H., Sancak, B. and Bukan, N. (2010) Lipid Peroxidation and Resistance to Oxidation in Patients with Type 2 Diabetes mellitus. Thoku Journal of Experimental Medicine. Pp.71-83.
Kassim, S. (2011). Comparative effect of Metformin and Glibenclamide on Lipid profile in type 2 Diabetic Patients. Tikrit Journal of Pharmaceutical Sciences. 7(1): 50-64
Kirpichnikov, D., McFarlane, S.I. and Sowers, J.R. (2002). Metformin: an update. Annual Internal Medicine. pg137.
Knowler, P.J., Voutilainen, E. and Aro, A. (1990). Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial. Annual Medical. pg307.
Krentz, A.J. and Bailey, C.J. (2001) Type 2 diabetes in practice. London: Royal Society of Medicine Press, pp.14-20.
Krishna, K., Sowmya, B., Mamata, B. and Naidu M.P. (2015). Effects of Glibenclamide and Glimepiride Compared in Type II DM Patients in Accordance with Lipid Parameters, ESF and Glycated Haemoglobin. British Journal of Applied Science & Technology. 10(3): 1-10.
Lida, K.T., Kawakami, Y., Suzuki, M., Shimano, H., Toyoshima, H. and Sone, H. (2003) Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats. American Journal Physiology Endocrinolology Metabolic. Pg. 284.
Marwan M. (2013). Effect of metformin, glibenclamide and insulin on lipid profile in type 2 diabetic patients. Tikrit Journal of Pharmaceutical Sciences. 9(2): 262-269.
Mohammed, S. A., Ibrahim, A.E., Hasan, A. and Yousif, E. (2016). Investigation on The Effect of Phytosterols on Lipid Profile, Journal of Pharmaceutical and Medicinal Research. 2(2): 60 61.
Njolstad, V.A., Bennett, N., Dodd, T., Flatley J. and Freeth, S. (2003) Diabetes Vital statistics for England, London; HMSO. Pp.19-91
Onat, A., Hergenc, G., Uyarel, H., Can, G. and Ozhan, H. (2006) Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. AnadoluKardiyolDerg. pp. 234.
Pasquali, R., Gambineri, A. and Biscotti, D. (2000). Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Journal Clinical Endocrinology Metabolism. Pp.45.
Penbe, G., Ursing, D. and Nilsson-Ehle, P. (2003). Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin action. European Journal Clinical Pharmacology. Pg. 279.
Petrovic, J., Maldenovic, M. and Djukic. A. (2010) Sipetic Lipid profile in type 2 diabetic patients in Kragujevac , Endocrine Abstracts. 22: 262.
Rains, S.G., Wilson G.A. and Richmond, W. (2002).The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabetic Medicine. Pg. 653.
Reaven, G., Scheniken, B. and Carlstrom, S. (2005). Ten year follow up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes. Pp. 45-50.
Reyadh, H. (2012). Effects of Metformin, Glyburide and their Combination on Lipid Profile in NIDDM Patients. Medical Journal of Babylon. 9(4): 936-945.
Robinson, A.C., Burke, J. and Robinson, S. (1998). The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care. 21:701-705.
REFRENCES -- [Total Page(s) 3]
Page 2 of 3
-
-
ABSRACT - [ Total Page(s): 1 ]Abstract Is Coming Soon ... Continue reading---
APPENDIX A - [ Total Page(s): 1 ]APPENDIX IQUESTIONAIRE TO ACCESS THE ANTHROPOLOGIC INDICES OF PATIENTS WITH TYPE TWO DIABETES MELLITUS ON ANTIDIABETIC DRUGS (METFORMIN AND GLIBENCLAMIDE) ATTENDING UITH ILORIN.INTRODUCTION: I am a final year students of the Department of Medical Laboratory Science, School of Basic Medical Sciences, Kwara State University, Malete, Kwara State. This questionnaire is aimed at accessing the demographic indices of patients with type 2 Diabetes mellitus on metformin and diabinese in Ilorin metropolis ... Continue reading---
APPENDIX B - [ Total Page(s): 5 ]Step 2100µl of the supernatant was dispensed into the clean test tubes respectively.2ml of the cholesterol reagent was addedIt was incubated at room temperature for 10minsAbsorbance of sample against reagent blank was measured at 505nmGlycated HaemoglobinGlycated Haemoglobin is a form of haemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average.ProcedureReagentsBlank(µl) samp ... Continue reading---
CHAPTER ONE - [ Total Page(s): 2 ]The present study was designed to investigate and compare the effects of glibenclamide and metformin on prevalence of metabolic syndrome in type 2 diabetic patients.1.2 STATEMENT OF PROBLEMTo know if antidiabetic agents glibenclamide and meltformine has any effect on lipid and glycated haemoglobin in type 2 diabetes patients1.3 AIM OF STUDYTo evaluate the effect of antidiabetic agent glibenclamide and meltformine on lipids and glycated haemoglobin in type 2 diabetes patient attendi ... Continue reading---
CHAPTER TWO - [ Total Page(s): 11 ]Triglycerides as major components of very low-density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice as much energy (approximately 9kcal/g or 38kj/g) as carbohydrates (approximately 4kcal/g or 17kj/g) (Brefere et al., 2014).2.5 Glycated hemoglobin (hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also referred to as being Hb1c or HGBA1C) is a form of hemoglobin that is measured primarily to i ... Continue reading---
CHAPTER THREE - [ Total Page(s): 1 ]CHAPTER THREE3.1 Material and Method3.2 Study AreaThe study was carried out at University of Ilorin Teaching Hospital, Ilorin, Kwara State. The hospital is located at the State capital of Ilorin, Kwara State Nigeria. It is a referral center to other public and private hospitals within and outside the state.3.3 SAMPLE SIZE DETERMINATIONThere was a random selection of ninety (90) subjects, 60 were type 2 Diabetes mellitus individual using either one or combine antidiabetic agent (glibe ... Continue reading---
CHAPTER FOUR - [ Total Page(s): 4 ]Tables 4.6: Correlation of Duration in Diabetes and BMI with biochemical parameters (T. cholesterol, High Density Lipoprotein, Low Density Lipoprotein, triglycerides, glycated, and fasting blood sugar) in Diabetic patient using antidiabetic drugs (Metformin and Glianpride). ... Continue reading---
CHAPTER FIVE - [ Total Page(s): 2 ]CHAPTER FIVE5.0 DISCUSSIONThe study shows discrepant results about the influence of metformin on lipid profile (10). Some studies, in agreement with ours, reported reduction only in TC levels (Grant, 1996; Ginsberg et al., 1999), while others reported reduction of TC and TG with an increase of HDL-C (Robinson et al., 1998; Yki-Jarvinen et al., 1999). Still other studies showed no changes in lipid profile (Groop et al., 1998; Rains et al., 1998). Another investigation showed an association of met ... Continue reading---
